Journal article
Activated Leukocyte Cell Adhesion Molecule Is a Marker for Thyroid Carcinoma Aggressiveness and Disease-Free Survival
Abstract
BACKGROUND: Currently, there are no protein biomarkers for aggressive subtypes of thyroid carcinomas (TC) in clinical use that would allow for early detection and patient management. We hypothesized that activated leukocyte cell adhesion molecule (ALCAM or CD166) expression in thyroid tissues will reveal ALCAM to be a potential diagnostic and/or prognostic marker for TC aggressiveness.
METHODS: Forty-five benign and 158 malignant thyroid …
Authors
Chaker S; Kak I; MacMillan C; Ralhan R; Walfish PG
Journal
Thyroid, Vol. 23, No. 2, pp. 201–208
Publisher
Mary Ann Liebert
Publication Date
February 2013
DOI
10.1089/thy.2012.0405
ISSN
1050-7256